Speakers



langer
Prof. Robert S. Langer Institute Professor, MIT
Schiermeier
Andrew D. Schiermeier Chief Operating Officer, Intellia Therapeutics
Niren
Niren Murthy Professor,  Department of Bioengineering at the University of California at Berkeley
Bhatia
Sangeeta Bhatia Professor MIT
nahrendorf
Matthias P Nahrendorf Professor of Radiology at Massachusetts General Hospital
Bradner
James (Jay) Bradner, M.D. President of the Novartis Institute for BioMedical Research
Konstantinov
Konstantin Konstantinov Ph. D. Executive VP, Codiak BioSciences
Afeyan
Noubar Afeyan Founder & CEO, Flagship Pioneering
Rotello
Vincent M. Rotello Professor of Chemistry, U Mass Amherst
Strano
Michael S. Strano Chemical Engineering MIT
 Bancel
Stephane Bancel Chief Executive Officer of Moderna
Chen
Zhengyi Chen Harvard Medical School, Associate Professor of Otaryngology
Verdine
Gregory Verdine President and CEO, Fog Pharma
Green
Jordan Green Johns Hopkins University
Mansoor
Mansoor M. Amiji University Distinguished Professor, Professor of Pharmaceutical Sciences, Northeastern University
albright
Charlie Albright Chief Scientific Officer of Editas Medicine
Irvine
Darrell Irvine Professor, MIT
Hammond
Paula T. Hammond Department Head, David H. Koch Professor, Department of Chemical Engineering, MIT
Shih
William Shih Harvard Medical School
Renaud
Ronald C. Renaud Jr. Chief Executive Officer of Translate
Fougerolles
Tony De Fougerolles CEO, Evox Therapeutics
Kaplan
David L. Kaplan Stern Family Professor of Engineering, Tufts University
Hanes
Justin Hanes, PhD Lewis J. Ort Professor of Ophthalmology, Johns Hopkins University
Alonso
Vasant Jadhav VP, Research, Alnylam Pharmaceuticals
Jadhav
Maria José Alonso Professor, Campus Vida -University of Santiago de Compostela, Spain, and President of the Controlled Release Society
Ho
Dr. Tony Ho Executive Vice President, Research and Development